Literature DB >> 27537771

Soluble Leptin Receptor and Risk of Gestational Diabetes in a Multiethnic Population: A Prospective Cohort Study.

Christine Sommer1, Hanne Løvdal Gulseth1, Anne Karen Jenum1, Line Sletner1, Per Medbøe Thorsby1, Kåre Inge Birkeland1.   

Abstract

CONTEXT: Soluble leptin receptor (sOb-R), a potential marker of leptin resistance, is inversely associated with risk of type 2 diabetes, independently of leptin concentrations. We have previously shown that ethnic difference in leptin concentration may partly explain the increased risk of gestational diabetes (GDM) in South Asians.
OBJECTIVE: Our objective was to investigate whether sOb-R concentrations are associated with risk of GDM, whether concentrations of sOb-R differ across ethnic groups, and whether ethnic differences in sOb-R explain the ethnic differences in GDM risk. DESIGN AND
SETTING: The STORK Groruddalen study; a prospective cohort study of pregnant women living in Oslo, Norway, between May 2008 and May 2010. PARTICIPANTS: Of the total sample (n = 823), 680 (47.1% Europeans) had sOb-R measured in pregnancy week 15 and an oral glucose tolerance test performed in week 28. MAIN OUTCOME MEASURE: GDM was diagnosed according to World Health Organization 2013 criteria.
RESULTS: sOb-R was inversely associated with GDM (odds ratio, 0.76 [95% confidence interval, 0.69-0.83] per ng/ml increase in sOb-R, P < .001) in crude analysis. The association was attenuated after adjustments for covariates and leptin (0.85 [0.77-0.95], P = .004). Compared to women with sOb-R higher than 5 ng/ml, the odds ratio of GDM was 0.29(0.11-0.78; P = .014) among women with sOb-R greater than 10 ng/ml and 0.59 (0.37-0.94; P = .026) among women with sOb-R 5-10 ng/ml, in adjusted analysis. sOb-R levels did not differ across ethnic groups, and sOb-R did not explain ethnic differences in GDM risk.
CONCLUSIONS: There was an independent, inverse association between sOb-R and GDM, with the lowest risk of GDM observed among higher sOb-R concentrations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27537771     DOI: 10.1210/jc.2016-2583

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Longitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesity.

Authors:  Ulrika Andersson-Hall; Pernilla Svedin; Henrik Svensson; Malin Lönn; Carina Mallard; Agneta Holmäng
Journal:  Int J Obes (Lond)       Date:  2019-09-24       Impact factor: 5.095

2. 

Authors:  Jonas Drąsutis; Arūnas Barkus; Elena Kairienė; Gražina Drąsutienė; Kristina Norvilaitė; Janina Tutkuvienė
Journal:  Acta Med Litu       Date:  2016

Review 3.  GDM-complicated pregnancies: focus on adipokines.

Authors:  Marta Mallardo; Sara Ferraro; Aurora Daniele; Ersilia Nigro
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

4.  Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort.

Authors:  Ellen C Francis; Mengying Li; Stefanie N Hinkle; Yaqi Cao; Jinbo Chen; Jing Wu; Yeyi Zhu; Haiming Cao; Karen Kemper; Lior Rennert; Joel Williams; Michael Y Tsai; Liwei Chen; Cuilin Zhang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.